Tamoxifen and the endometrium: Findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients

Breast Cancer Research and Treatment

Volumn 47, Issue 1, 1998, Pages 41-46

  Bertelli, Gianfilippo ^a   Venturini, Marco ^a   Del Mastro, Lucia ^a   Garrone, Ornella ^a   Cosso, Maurizio ^a   Gustavino, Claudio ^a   Cusimano, Enzo ^a   Guido, Tiziana ^a   Nicolò, Guido ^a   Rosso, Riccardo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Adjuvant therapy; Endometrial biopsy; Endometrial cancer; Tamoxifen; Ultrasonography

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYST; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PELVIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; STENOSIS; ULTRASOUND; UTERINE CERVIX; UTERUS; VAGINA BLEEDING; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; ENDOMETRIUM; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; TAMOXIFEN;

EID: 6844240215     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005820115535     Document Type: Article

References (24)

1. Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN: Use of tamoxifen for breast cancer: Twenty-eight years later. J Clin Oncol 13: 513-529, 1995
2. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM, and other NASBP Contributors: Endometrial cancer in tamoxifen-trcated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86: 527-537, 1994
3. Jordan VC, Morrow M: Should clinicians be worried about the carcinogenic potential of tamoxifen? Eur J Cancer 30A: 1714-1721, 1994
4. Neven P, De Muylder X, Van Belle Y, Campo R, Vanderick G: Tamoxifen and the uterus. Br Med J 309: 1313-1314, 1994
5. Hulka CA, Hall DA, McCarthy K, Simeone JF: Endometrial polyps, hyperplasia, and carcinoma in postmenopausal women: differentiation with endovaginal sonography. Radiology 191: 755-758, 1994
6. Ciatto S, Cecchini S, Bonardi R, Grazzini G: Ultrasonography surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 344: 60, 1994
7. Barakat RR, Gilewski TA, Saigo PE, Almadrones L, Tyson P, Norton L, Hoskins WJ: The effect of adjuvant tamoxifen on the endometrium in women with breast cancer: an interim analysis of a prospective study. Proc Am Soc Clin Oncol 14: 227, 1995 (abs)
8. Schwartz PE: Gynecologic surveillance of women taking tamoxifen. Conn Med 58: 515-521, 1994
9. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31.000 recurrences and 24.000 deaths among 75.000 women. Lancet 339: 1-15, 71-85, 1992
10. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852-856, 1992
11. Love RR, Wiebe DA, Feyzi JM, Newcomb PA, Chappell RJ: Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 6 years of treatment. J Natl Cancer Inst 86: 1534-1539, 1994
12. Ziel HK: Estrogen's role in endometrial cancer. Obstet Gynecol 60: 509-515, 1982
13. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343: 1318-1321, 1994
14. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81: 660-664, 1993
15. Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y: Endometrial changes with tamoxifen: comparison between treated and non-treated asymptomatic postmenopausal breast cancer patients. Gynecol Oncol 52: 185-190, 1994
16. Rayter Z, Gazet JC, Sheperd J, Trott PA, Fisher C, Svensson WE, Ford HT, Hern RA: Gynecological cytology and pelvic ultrasonography in patients with breast cancer taking tamoxifen compared with controls. Eur J Surg Oncol 20: 134-140, 1994
17. Bornstein J, Auslender R, Pascal B, Gutterman E, Isakov D, Abramovici H: Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen. J Reprod Med 39: 674-678, 1994
18. Goldstein S: Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170: 447-451, 1994
19. Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A: Effect of tamoxifen on endometrial proliferation. J Clin Oncol 14: 434-440, 1996
20. Aleem FA, Predanic M: Endometrial changes in patients on tamoxifen. Lancet 346: 1292-1293, 1995
21. Achiron R, Lipitz S, Sivan E, Goldenberg M, Horovitz A, Frenkel Y, Mashiach S: Changes mimicking endometrial neoplasia in postmenopausal tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol 6: 116-120, 1995
22. Tepper R, Cohen I, Altaras M, Shapira J, Cordoba M, Dror Y, Beyth Y: Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. J Ultrasound Med 13: 635-640, 1994
23. Achiron R, Lipitz S, Sivan E, Goldenberg M, Mahiach S: Sonohysterography for ultrasonograhic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 14: 685-688, 1995
24. Ascher SM, Johnson JC, Barnes WA, Bae CJ, Patt RH, Zeman RK: MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology 200: 105-110, 1996